MYTESI
NDC 70564-802, Crofelemer, tablet, coated, from Napo Pharmaceuticals, Inc..
- Product NDC
- 70564-802
- Status
- Listed
- Labeler
- Napo Pharmaceuticals, Inc.
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA202292
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70564-802 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CROFELEMER125 mg/1
Pharmacologic classes
Antidiarrheal [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70564-802-60 | 70564080260 | 60 TABLET, COATED in 1 BOTTLE (70564-802-60) |
| 70564-802-99 | 70564080299 | 60 TABLET, COATED in 1 BOTTLE (70564-802-99) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/45584fba-8081-4cd1-a21e-3ea8237f62ff
Use it
Look up 70564-802 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70564-802 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70564-802. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.